Blog

KDIGO Connections: ADPKD in Kidney Transplant Candidates

Published: October 18, 2019
By: David Bourne, MD

ADPKD, ADPKD in Kidney Transplant Candidates, KDIGO, Arkana Laboratories, Dr. David Bourne, kidney diseases

Kidney transplant donors and autosomal dominant polycystic kidney disease.

Published: October 4, 2019
By: David Bourne, MD

KDIGO offers some future directions for studying MGRS lesions.

Published: September 20, 2019
By: David Bourne, MD
Tags: Chronic kidney disease, DNAJB9, Fibrillary glomerulopathy, Fibrils

If you have taken care of patients with fibrillary glomerulopathy, what has been the outcome?

Published: August 9, 2019
By: David Bourne, MD
Tags: lupus vasculopathy, SLE, systemic lupus erythematosus, Thrombotic microangiopathy, TMA

Remember to think about TMA lesions in your patients with lupus!

Published: July 29, 2019
By: David Bourne, MD
Tags: Class III, Class IV, Lupus nephritis, Necrotizing and crescentic glomerulonephritis, SLE, systemic lupus erythematosus

How do you initially treat patients with active lupus nephritis?

Published: July 12, 2019
By: David Bourne, MD
Tags: Acute tubular injury, Contrast associated kidney injury, management guidelines, osmotic

Management guidelines and "contrasting" opinion regarding contrast-associated acute kidney injury.

Published: June 14, 2019
By: David Bourne, MD
Tags: KDIGO, Membranous glomerulopathy, PLA2R, Proteinuria

Have you seen the latest proposed KDIGO algorithm for the diagnosis and treatment of membranous glomerulopathy? Dr. Bourne brings us an all-new KDIGO Connections visual abstract today!

Published: May 31, 2019
By: David Bourne, MD
Tags: Cryoglobulinemia, HCV, Hepatitis C, KDIGO, Membranoproliferative glomerulonephritis, MPGN, Proteinuria

How do you treat patients with hepatitis C-associated kidney disease?

Published: May 3, 2019
By: David Bourne, MD
Tags: Acute kidney injury, aHUS, Hemolytic uremic syndrome, Thrombotic microangiopathy

How do you treat patients with atypical hemolytic-uremic syndrome?

Published: April 5, 2019
By: David Bourne, MD
Tags: ANCA, corticosteroids, Crescents, cyclophosphamide, IVIG, necrosis, plasmapheresis

How do you manage your patients who have refractory ANCA-related glomerulonephritis?

12 3 »›

Blog

Accordion Archives

KDIGO Connections: ADPKD in Kidney Transplant Candidates

KDIGO Connections: MGRS

KDIGO Connections: Fibrillary Glomerulopathy

KDIGO Connections: SLE and TMA

KDIGO Connections: SLE Treatment and Definitions

KDIGO Connections: Contrast Induced AKI

KDIGO Connections: Membranous Diagnosis Algorithm

KDIGO Connections: HCV-Associated Kidney Disease

KDIGO Connections: aHUS

KDIGO Connections: ANCA Refactory

Arkana
Announcement

Doctor's Log In

Blog

Accordion Archives

Arkana Announcement

Arkana
Announcement